Skip to main content
Log in

A Prospective Multicenter Randomized Controlled Trial for Comparing Drug-Coated and Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of Hemodialysis Arteriovenous Grafts

  • Clinical Investigation
  • VENOUS INTERVENTIONS
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the efficacy and safety of drug-coated balloon angioplasty compared to conventional balloon angioplasty in the treatment of dysfunctional arteriovenous grafts.

Materials and Methods

This prospective, multicenter, randomized clinical trial enrolled 190 patients with venous anastomotic stenosis in arteriovenous grafts at five participating hospitals. During pre-dilation, 4 patients dropped out due to ruptures requiring further treatment (n = 2) and residual stenosis of > 30% (n = 2). On successful pre-dilation with a 7 mm conventional balloon, patients were randomized to undergo either a 7 mm drug-coated balloon (n = 94) or conventional balloon angioplasty (n = 92).

The primary out-come measure was target lesion primary patency at 3 and 6 months. The secondary out-come measures included target lesion primary patency at 12 months and access circuit primary patency at 6 and 12 months, clinical and technical success rates, and 12-month mortality differences between the groups.

Results

The target lesion primary patency and access circuit patency rates at 3 and 6 months were significantly higher in drug-coated balloon angioplasty group as compared to conventional balloon angioplasty group. The technical and clinical success rates were 100% for both the groups. As a procedure-related complication, anastomotic site rupture occurred during pre-dilation in 4 cases. The number of deaths during the 12-month follow-up was one for each group. The number of early thrombotic events (at < 3 months) was significantly higher in the drug-coated balloon group (p = 0.002).

Conclusion

Drug-coated balloon angioplasty was more effective and safer for the treatment of dysfunctional arteriovenous grafts compared to conventional balloon angioplasty.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC. Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol. 2008;19:877–83. https://doi.org/10.1016/j.jvir.2008.02.016.

    Article  PubMed  Google Scholar 

  2. Glanz S, Gordon DH, Butt KM, Hong J, Lipkowitz GS. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg. 1987;206:777–81. https://doi.org/10.1097/00000658-198712000-00015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Trerotola SO, Stavropoulos SW, Shlansky-Goldberg R, Tuite CM, Kobrin S, Rudnick MR. Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons. Radiology. 2004;231:259–62. https://doi.org/10.1148/radiol.2311030949.

    Article  PubMed  Google Scholar 

  4. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75:s1–164. https://doi.org/10.1053/j.ajkd.2021.02.002.

    Article  PubMed  Google Scholar 

  5. Maleux G, Mijnsbrugge WV, Henroteaux D, Laenen A, Cornelissen S, Claes K, et al. Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae. J Vasc Interv Radiol. 2018;29:470–5. https://doi.org/10.1016/j.jvir.2017.10.023.

    Article  PubMed  Google Scholar 

  6. Kennedy SA, Mafeld S, Baerlocher MO, Jaberi A, Rajan DK. Drug-Coated balloon angioplasty in hemodialysis circuits: a systematic review and meta-analysis. J Vasc Interv Radiol. 2019;30:483–94. https://doi.org/10.1016/j.jvir.2019.01.012.

    Article  PubMed  Google Scholar 

  7. Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383:733–42. https://doi.org/10.1056/nejmoa1914617.

    Article  CAS  PubMed  Google Scholar 

  8. Lia MT, Lee CP, Lin TT, Jong CB, Chen TY, Lin L, et al. A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts. J Vasc Surg. 2020;71:1994–2003. https://doi.org/10.1016/j.jvs.2019.07.090.

    Article  Google Scholar 

  9. Gray RJ, Sacks D, Martin LG, Trerotola SO. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol. 2003;14:S433–42. https://doi.org/10.1097/01.rvi.0000094618.61428.58.

    Article  PubMed  Google Scholar 

  10. Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362:494–503. https://doi.org/10.1056/nejmoa0902045.

    Article  CAS  PubMed  Google Scholar 

  11. Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. J Vasc Surg. 2016;64:1400–10. https://doi.org/10.1016/j.jvs.2016.04.035.

    Article  PubMed  Google Scholar 

  12. Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012;19:263–72. https://doi.org/10.1583/11-3690.1.

    Article  PubMed  Google Scholar 

  13. Kitrou PM, Spiliopoulos S, Katsanos K, Papachristou E, Siablis D, Karnabatidis D. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2015;26:348–54. https://doi.org/10.1016/j.jvir.2014.11.003.

    Article  PubMed  Google Scholar 

  14. Lai CC, Fang HC, Tseng CJ, Liu CP, Mar GY. Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study. J Vasc Interv Radiol. 2014;25:535–41. https://doi.org/10.1016/j.jvir.2013.12.014.

    Article  PubMed  Google Scholar 

  15. Rokoszak V, Syed MH, Salata K, Greco E, de Mestral CD, Hussain MA, et al. A systematic review and meta-analysis of plain versus drug-eluting balloon angioplasty in the treatment of juxta-anastomotic hemodialysis arteriovenous fistula stenosis. J Vasc Surg. 2020;71:1046–54. https://doi.org/10.1016/j.jvs.2019.07.075.

    Article  PubMed  Google Scholar 

  16. Trerotola SO, Lawson J, Roy-Chaudhury P, Saad TF. Drug coated balloon angioplasty in failing av fistulas: a randomized controlled trial. Clin J Am Soc Nephrol. 2018;13:1215–24. https://doi.org/10.2215/cjn.14231217.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Liao MT, Chen MK, Hsieh MY, Yeh NL, Chien KL, Lin CC, et al. Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2020;15:e0231463. https://doi.org/10.1371/journal.pone.0231463.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Luo C, Liang M, Liu Y, Zheng D, He Q, Jin J. Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized controlled trials. Ren Fail. 2022;44:155–70. https://doi.org/10.1080/0886022x.2022.2029487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Trerotola SO, Saad TF, Roy-Chaudhury P, Lutonix AV. Clinical trial investigators. The lutonix AV randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2-year results and subgroup analysis. J Vasc Interv Radiol. 2020;31:1-14.e5. https://doi.org/10.1016/j.jvir.2019.08.035.

    Article  PubMed  Google Scholar 

  20. Lee HS, Kang J, Park KW, Ki YJ, Chang M, Han JK, et al. Procedural optimization of drug-coated balloons in the treatment of coronary artery disease. Catheter Cardiovasc Interv. 2021;98:E43–52. https://doi.org/10.1002/ccd.29492.

    Article  PubMed  Google Scholar 

  21. Dinh K, Limmer AM, Paravastu SCV, Thomas SD, Bennett MH, Holden A, et al. Mortality after paclitaxel-coated device use in dialysis access: a systematic review and meta-analysis. J Endovasc Ther. 2019;26:600–12. https://doi.org/10.1177/1526602819872154.

    Article  PubMed  Google Scholar 

  22. van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, Rensing BJ, et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation. 2009;119:828–34. https://doi.org/10.1161/circulationaha.108.799403.

    Article  PubMed  Google Scholar 

  23. Kim SM, Ko HK, Noh M, Ko GY, Kim MJ, Kwon TW, et al. Factors affecting patency following successful percutaneous intervention for dysfunctional hemodialysis vascular access. Ann Vasc Surg. 2018;47:54–61. https://doi.org/10.1016/j.avsg.2017.08.003.

    Article  PubMed  Google Scholar 

  24. Zheng Q, Xie B, Xie X, Zhang W, Hou J, Feng Z, et al. Predictors associated with early and late stenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography. Ann Transl Med. 2021;9:132.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Neuen BL, Gunnarsson R, Baer RA, Tosenovsky P, Green SJ, Golledge J, et al. Factors associated with patency following angioplasty of hemodialysis fistula. J Vasc Interv Radiol. 2014;25:1419–26. https://doi.org/10.1016/j-jvir.2014.05.020.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Authors thank SH Kwon and HJ Noh (nephrologists) for their help in the follow-up of the patients. We also thank SH Park for statistical advice and support.

Author information

Authors and Affiliations

Authors

Contributions

DE Goo and SW Park were in charge of the study conception and design. Material preparation and data collection were performed by DE Goo, YJ Kim, SW park, HJ Cheon, YD Won, and SB Yang. The first manuscript was written by DE Goo and SW Park, and all authors read and approved the final manuscript.

Corresponding author

Correspondence to Dong Erk Goo.

Ethics declarations

Conflict of interest

This study was financially supported by Medtronic.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goo, D.E., Kim, Y.J., Park, S.W. et al. A Prospective Multicenter Randomized Controlled Trial for Comparing Drug-Coated and Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of Hemodialysis Arteriovenous Grafts. Cardiovasc Intervent Radiol 47, 36–44 (2024). https://doi.org/10.1007/s00270-023-03536-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-023-03536-5

Keywords

Navigation